IRADIMED CORPORATION (IRMD) FY2026 YTD Q2 P&L / Income Statement

IRADIMED CORPORATION (IRMD) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue

42,444,000 US dollars

Cost of revenue

10,471,000 US dollars

Gross profit

31,973,000 US dollars

Total operating expenses

18,346,000 US dollars

Income from operations

13,627,000 US dollars

Other income, net

1,030,000 US dollars

Income before provision for income taxes

14,657,000 US dollars

Provision for income tax expense

3,621,000 US dollars

Net income

11,036,000 US dollars

UNITED STATES

34,745,000 US dollars

International

7,699,000 US dollars

General and administrative

8,435,000 US dollars

Sales and marketing

8,298,000 US dollars

Research and development

1,613,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.